Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$67,561,861
+$22,980,650 QoQ
Shares Held
266,023
+45.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#383
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Employees Provident Fund Board holds $1,255,262,333 across 8 Drug Manufacturers - General names. JNJ ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
518,259 | $621,615,444 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,640,333 | $209,755,987 | |
| 3 | BIIB |
Biogen Inc.
|
704,196 | $152,148,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
535,502 | $68,812,007 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
266,023 | $67,561,861 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
488,657 | $61,736,925 | |
| 7 | ABBV |
AbbVie Inc.
|
163,093 | $41,040,722 | |
| 8 | AMGN |
Amgen Inc
|
90,000 | $32,590,800 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,561,861 | 266,023 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $44,581,211 | 182,381 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $49,995,808 | 241,584 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $44,789,498 | 241,557 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $35,208,875 | 230,500 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $16,430,763 | 99,076 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $16,631,300 | 115,000 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $14,342,310 | 88,500 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $13,987,512 | 95,700 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $13,683,435 | 86,500 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $13,322,900 | 85,000 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $12,615,750 | 81,000 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $9,914,648 | 59,900 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $7,767,980 | 50,116 | Shares | Sole | 2026-03-18 | |
| 2022-12-31 | $2,711,577 | 15,350 | Shares | Sole | 2026-03-18 | |
| 2022-09-30 | $2,826,128 | 17,300 | Shares | Sole | 2026-03-18 | |
| 2022-06-30 | $1,899,357 | 10,700 | Shares | Sole | 2026-03-18 | |
| 2022-03-31 | $921,596 | 5,200 | Shares | Sole | 2026-03-18 | |
| 2021-12-31 | $718,494 | 4,200 | Shares | Sole | 2026-03-18 | |
| 2021-06-30 | $46,986,483 | 285,216 | Shares | Sole | 2026-03-18 | |
| 2021-03-31 | $46,875,249 | 285,216 | Shares | Sole | 2026-03-18 | |
| 2020-12-31 | $59,849,725 | 380,288 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $53,876,396 | 361,878 | Shares | Sole | 2026-03-20 | |
| 2020-06-30 | $47,775,245 | 339,723 | Shares | Sole | 2026-03-31 | |
| 2020-03-31 | $11,302,094 | 86,190 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||